The dialysis-services company saw solid revenue growth and raised its guidance for the full 2015 year. NxStage keeps on climbing NxStage Medical's second-quarter results gave investors much of what ...

The medical technology company inches closer to profitability thanks primarily to improving System One sales. NxStage reported its second-quarter results before the markets opened on Thursday. Did ...

NxStage Medical, Inc. NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...

NxStage Medical, Inc. NXTM recently announced that its subsidiary NxStage Kidney Care is partnering Dialyze Direct for supporting the needs of patients who need on-site skilled-nursing facilities (SNF ...

NxStage Medical's home dialysis treatment offers convenience. Source: NxStage. The incidence of chronic kidney disease and diabetes has risen sharply in the U.S. in recent years, and that has required ...

While the strategic rationale behind Fresenius Medical Care's $2 billion bid for NxStage Medical is clear, the timing of the deal is vague. Amanda Pedersen As Fresenius Medical Care kicked off a ...

Explore NxStage stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and find the highest NxStage ...

NxStage Medical (NASDAQ: NXTM) has been in limbo since mid-2017, when it received an offer from Fresenius Medical Care (NYSE: FMS) to buy the company. Since then, shares of NxStage have stayed ...

NxStage Medical(NASDAQ: NXTM) is down almost 15% at 12:21 p.m. EDT after releasing first-quarter earnings in which the company cut its 2017 outlook for the future. The first quarter wasn't so bad, ...